Patent ID: 12239811

DETAILED DESCRIPTION

The present technology relates to implantable medical devices such as vascular access devices and associated systems and methods of use. Some embodiments of the present technology, for example, are directed to wireless charging and localization of such implantable devices. Some embodiments are directed to methods and systems for secure data communication between an implantable device and external computing devices. Specific details of several embodiments of the technology are described below with reference toFIGS.1-9B.

Conventional vascular access devices are bulky by design to allow a clinician to localize the device by palpation. To be accurately accessed by a clinician, the vascular access device needs to be either visualized or palpated under the skin. Reducing the profile and/or the footprint of the device may improve patient comfort. However, this reduction may render the device more difficult to locate using palpation alone. Additionally, conventional vascular access ports have no electronic components and do not require an internal power source.

Advanced vascular access devices may be equipped with electronic components to provide a platform for remote patient monitoring technology. For example, an implanted vascular access device may contain an array of physiologic sensors that monitor a patient's physiological parameters, enabling early warning systems, alerting patients and their healthcare teams when there is a risk of illness or complications from therapy. Additionally, the implanted device may contain data storage and communication technology that not only monitors physiologic parameters, but also contains information about the patient's demographics, diagnoses, treatment history, and POLST (Physician Order for Life Sustaining Treatment) status.

As described in more detail below, a vascular access device equipped with physiological sensors and other electronics may be configured for wireless communication with an interrogation device or other remote computing device. In response to communication with the interrogation device, the vascular access device may emit a localization signal that facilitates a clinician's identification of the location of the device. For example, the localization signal can be emitted light that transilluminates a patient's skin, vibrating elements, magnets that create a signature magnetic field, etc. The interrogation device may also wirelessly recharge a battery of the vascular access device, for example via inductive charging.

In some embodiments, the vascular access device may transmit patient data (e.g., physiological measurements, patient medical record data, etc.) to the interrogation device or other remote computing device. Storage and transmission of such sensitive patient data require new techniques for maintaining data security while enabling remote monitoring and communication. Currently available electronically controlled implantable devices exist, including pacemakers, defibrillators, and nerve stimulators. Some of these devices wirelessly communicate data to physicians through home base stations or by telephone, inciting patient data security concerns. Conventional wearable monitors also illicit privacy concerns related to traceability of location, as well as personal physiological data. In some cases, these data have generated security concerns for military personnel. Next generation data security innovations are necessary to combat these privacy and security concerns. Accordingly, as described in more detail below, the vascular access device may obfuscate the patient data (e.g., using a combination of encryption and other related techniques) to maintain security of the data while transmitting the data wirelessly to the interrogation device.

Patient Monitoring System Overview

FIG.1is a schematic representation of a system10for monitoring the health of a patient via a vascular access device100(or “device100”) in accordance with the present technology. The device100is configured to be implanted within a human patient H, such as at a subcutaneous location along an upper region of the patient's chest. As shown inFIG.1, the device100may include a sensing element110configured to obtain physiological measurements that are used by the system10to determine one or more physiological parameters indicative of the patient's health. In some embodiments, the system10may detect a medical condition (such as sepsis) or associated symptom(s) based on the physiological parameter(s) and provide an indication of the detected condition to the patient, caregiver, and/or medical care team.

As shown schematically inFIG.1, the device100may be configured to communicate wirelessly with a local computing device150, which can be, for example, a smart device (e.g., a smartphone, a tablet, or other handheld device having a processor and memory), a special-purpose interrogation device, or other suitable device. Communication between the device100and the local computing device150can be mediated by, for example, near-field communication (NFC), infrared wireless, Bluetooth, ZigBee, Wi-Fi, inductive coupling, capacitive coupling, or any other suitable wireless communication link. The device100may transmit data including, for example, physiological measurements obtained via the sensing element110, patient medical records, device performance metrics (e.g., battery level, error logs, etc.), or any other such data stored by the device100. In some embodiments, the transmitted data is encrypted or otherwise obfuscated to maintain security during transmission to the local computing device150. The local computing device150may also provide instructions to the vascular access device100, for example to obtain certain physiological measurements via the sensing element110, to emit a localization signal, or to perform other functions. In some embodiments, the local computing device150may be configured to wirelessly recharge a battery of the device100, for example via inductive charging.

The system10may further include first remote computing device(s)160(or server(s)), and the local computing device150may in turn be in communication with first remote computing device(s)160over a wired or wireless communications link (e.g., the Internet, public and private intranet, a local or extended Wi-Fi network, cell towers, the plain old telephone system (POTS), etc.). The first remote computing device(s)160may include one or more own processor(s) and memory. The memory may be a tangible, non-transitory computer-readable medium configured to store instructions executable by the processor(s). The memory may also be configured to function as a remote database, i.e., the memory may be configured to permanently or temporarily store data received from the local computing device150(such as one or more physiological measurements or parameters and/or other patient information).

In some embodiments, the first remote computing device(s)160can additionally or alternatively include, for example, server computers associated with a hospital, a medical provider, medical records database, insurance company, or other entity charged with securely storing patient data and/or device data. At a remote location170(e.g., a hospital, clinic, insurance office, medical records database, operator's home, etc.), an operator may access the data via a second remote computing device172, which can be, for example a personal computer, smart device (e.g., a smartphone, a tablet, or other handheld device having a processor and memory), or other suitable device. The operator may access the data, for example, via a web-based application. In some embodiments, the obfuscated data provided by the device100can be de-obfuscated (e.g., unencrypted) at the remote location170.

In some embodiments, the device100may communicate with remote computing devices160and/or170without the intermediation of the local computing device150. For example, the vascular access device100may be connected via Wi-Fi or other wireless communications link to a network such as the Internet. In other embodiments, the device100may be in communication only with the local computing device150, which in turn is in communication with remote computing devices160and/or170.

FIG.2shows an example of a vascular access device100(or “device100”) configured for use with the system10of the present technology. As shown inFIG.2, the device100comprises a housing102configured to be implanted within a human patient, a fluid reservoir104contained within the housing102, and a self-sealing septum106adjacent the reservoir104and configured to receive a needle therethrough for delivery of a therapeutic agent to the reservoir104(as described in greater detail below with respect toFIG.3). The housing102may be made of a biocompatible plastic, metal, ceramic, medical grade silicone, or other material that provides sufficient rigidity and strength to prevent needle puncture. The self-sealing septum106can be, for example, a membrane made of silicone or other deformable, self-sealing, biocompatible material. In some embodiments, the device100may include a catheter130that extends distally from the housing102and is in fluid communication with the reservoir104. For example, the catheter130can be configured to mate with an outlet port of the device100via a barb connector or other suitable mechanical connection. The catheter130may be a single or multi-lumen catheter. In some embodiments, the device100includes multiple separate catheters.

As shown inFIG.3, in operation the device100is implanted in a patient beneath the skin S, for example in a small pocket created in the upper chest wall just inferior to the clavicle. The catheter130, which is in fluid communication with the reservoir104, is inserted into a blood vessel V, for example the internal jugular vein or the subclavian vein with the tip resting in the superior vena cava or the right atrium. A clinician inserts a needle N (e.g., a non-coring or Huber-type needle) through the skin S, through the self-sealing septum106, and into the fluid reservoir104. To introduce fluid (e.g., medication) into the patient's blood vessel V, the clinician may advance fluid through the needle N, which then flows through the reservoir104, the catheter130, and into the vessel V, or the physician may advance fluid through the needle to fill the reservoir for postponed delivery into the vessel V. To remove fluid from the vessel V (e.g., to aspirate blood from the vessel V for testing), the clinician can apply suction via the needle N, thereby withdrawing fluid (e.g., blood) from the vessel V into the catheter130, into the fluid reservoir104, and into the needle N. When the procedure is completed, the clinician removes the needle N, the self-sealing septum106resumes a closed configuration, and the device100may remain in place beneath the patient's skin S.

Referring again toFIG.2, as previously mentioned, the device10includes a sensing element110coupled to the housing102and configured to obtain physiological measurements. Although a single sensing element110is illustrated for clarity, in various embodiments, the device100may include a plurality of sensing elements110disposed within or otherwise coupled to the housing102. In some embodiments, one or more such sensing elements110may be disposed on separate structural components that are separated from the housing102. As used herein, the term “sensing element” may refer to a single sensor or a plurality of discrete, separate sensors.

The device100may include at least one controller112communicatively coupled to the sensing element110. The controller112may include one or more processors, software components, and memory (not shown). In some examples, the one or more processors include one or more computing components configured to process the physiological measurements received from the sensing element110according to instructions stored in the memory. The memory may be a tangible, non-transitory computer-readable medium configured to store instructions executable by the one or more processors. For instance, the memory may be data storage that can be loaded with one or more of the software components executable by the one or more processors to achieve certain functions. In some examples, the functions may involve causing the sensing element110to obtain physiological data from the patient. In another example, the functions may involve processing the physiological data to determine one or more physiological parameters and/or provide an indication to the patient and/or clinician of one or more symptoms or medical conditions associated with the determined physiological parameters.

The controller112may also include a data communications unit configured to securely transmit data between the device100and external computing devices (e.g., local computing device150, remote computing devices160and170, etc.). In some embodiments, the controller112includes a localization unit configured to emit a localization signal (e.g., lights that transilluminate a patient's skin, vibration, a magnetic field, etc.) to aid a clinician in localizing the device100when implanted within a patient. The controller112can also include a wireless charging unit105(such as a coil) configured to recharge a battery (not shown) of the device100when in the presence of an interrogation device (e.g., local device150or another suitable device).

The system10may be configured to continuously and/or periodically obtain physiological measurements via the sensing element110in communication with the device100. The sensing element110may be carried by the housing102and/or the catheter130, and/or may include a sensing component separate from the housing102and catheter130but physically or communicatively coupled to the housing102and/or catheter130. The sensing element110may be implanted at the same location as the device100or at a different location, or may be positioned on the patient at an exterior location (e.g., on the patient's skin). The sensing element110may be permanently coupled to the device100, or may be configured to temporarily couple to the device100.

In some embodiments, the sensing element110is built into the housing102such that only a portion of the sensing element110is exposed to the local physiological environment when the device100is implanted. For example, the sensing element110may comprise one or more electrodes having an external portion positioned at an exterior surface of the housing102and an internal portion positioned within the housing102and wired to the controller112. In some embodiments the sensing element110may be completely contained within the housing102. For example, the sensing element110may comprise a pulse oximeter enclosed by the housing102and positioned adjacent a window in the housing102through which light emitted from the pulse oximeter may pass to an external location, and back through which light reflected from the external location may pass for detection by a photodiode of the pulse oximeter. In such embodiments the window may be, for example, a sapphire window that is brazed into place within an exterior wall of the housing102.

The sensing element110may comprise at least one sensor completely enclosed by the housing102and at least one sensor that is partially or completely positioned at an external location, whether directly on the housing102and/or catheter130or separated from the housing102and/or catheter130(but still physically coupled to the housing102and/or catheter130via a wired connection, for example.)

In some embodiments, the sensing element110may include a separate controller (not shown) that comprises one or more processors and/or software components. In such embodiments, the sensing element110may process at least some of the physiological measurements to determine one or more physiological parameters, and then transmit those physiological parameters to the controller112of the device100(with or without the underlying physiological data). In some examples, the sensing element110may only partially process at least some of the physiological measurements before transmitting the data to the controller112. In such embodiments, the controller112may further process the received physiological data to determine one or more physiological parameters. The local computing device150and/or the remote computing devices160,170may also process some or all of the physiological measurements obtained by the sensing element110and/or physiological parameters determined by the sensing element110and/or the controller112.

According to some aspects of the technology, the sensing element110may include memory. The memory may be a non-transitory computer-readable medium configured to permanently and/or temporarily store the physiological measurements obtained by the sensing element110. In those embodiments where the sensing element110includes its own processor(s), the memory may be a tangible, non-transitory computer-readable medium configured to store instructions executable by the processor(s).

In some embodiments, the sensing element(s)110and/or controller112may identify, monitor, and communicate patient information by electromagnetic, acoustic, motion, optical, thermal, or biochemical sensing elements or means. The sensing element(s)110may include, for example, one or more temperature sensing elements (e.g., one or more thermocouples, one or more thermistors or other type of resistance temperature detector, etc.), one or more impedance sensing elements (e.g., one or more electrodes), one or more pressure sensing elements, one or more optical sensing elements, one or more flow sensing elements (e.g., a Doppler velocity sensing element, an ultrasonic flow meter, etc.), one or more ultrasonic sensing elements, one or more pulse oximeters, one or more chemical sensing elements, one or more movement sensing elements (e.g., one or more accelerometers), one or more pH sensing elements, an electrocardiogram (“ECG”) unit, one or more electrochemical sensing elements, one or more hemodynamic sensing elements, and/or other suitable sensing devices.

The sensing element110may comprise one or more electromagnetic sensing elements configured to measure and/or detect, for example, impedance, voltage, current, or magnetic field sensing capability with a wire, wires, wire bundle, magnetic node, and/or array of nodes. The sensing element110may comprise one or more acoustic sensing elements configured to measure and/or detect, for example, sound frequency, within human auditory range or below or above frequencies of human auditory range, beat or pulse pattern, tonal pitch melody, and/or song. The sensing element110may comprise one or more motion sensing elements configured to measure and/or detect, for example, vibration, movement pulse, pattern or rhythm of movement, intensity of movement, and/or speed of movement. Motion communication may occur by a recognizable response to a signal. This response may be by vibration, pulse, movement pattern, direction, acceleration, or rate of movement. Motion communication may also be by lack of response, in which case a physical signal, vibration, or bump to the environment yields a motion response in the surrounding tissue that can be distinguished from the motion response of the sensing element110. Motion communication may also be by characteristic input signal and responding resonance. The sensing element110may comprise one or more optical sensing elements which may include, for example, illuminating light wavelength, light intensity, on/off light pulse frequency, on/off light pulse pattern, passive glow or active glow when illuminated with special light such as UV or “black light”, or display of recognizable shapes or characters. It also includes characterization by spectroscopy, interferometry, response to infrared illumination, and/or optical coherence tomography. The sensing element110may comprise one or more thermal sensing elements configured to measure and/or detect, for example, device100temperature relative to surrounding environment, the temperature of the device100(or portion thereof), the temperature of the environment surrounding the device100and/or sensing element110, or differential rate of the device temperature change relative to surroundings when the device environment is heated or cooled by external means. The sensing element110may comprise one or more biochemical devices which may include, for example, the use of a catheter, a tubule, wicking paper, or wicking fiber to enable micro-fluidic transport of bodily fluid for sensing of protein, RNA, DNA, antigen, and/or virus with a micro-array chip.

In some aspects of the technology, the controller112and/or sensing element110may be configured to detect and/or measure the concentration of blood constituents, such as sodium, potassium, chloride, bicarbonate, creatinine, blood urea nitrogen, calcium, magnesium, and phosphorus. The system10and/or the sensing element110may be configured to evaluate liver function (e.g., by evaluation and/or detection of AST, ALT, alkaline phosphatase, gamma glutamyl transferase, troponin, etc.), heart function (e.g., by evaluation and/or detection of troponin), coagulation (e.g., via determination of prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR)), and/or blood counts (e.g., hemoglobin or hematocrit, white blood cell levels with differential, and platelets). In some embodiments, the system10and/or the sensing element110may be configured to detect and/or measure circulating tumor cells, circulating tumor DNA, circulating RNA, multigene sequencing of germ line or tumor DNA, markers of inflammation such as cytokines, C reactive protein, erythrocyte sedimentation rate, tumor markers (PSA, beta-HCG, AFP, LDH, CA 125, CA 19-9, CEA, etc.), and others.

As previously mentioned, the system10may determine one or more physiological parameters based on the physiological measurements and/or one or more other physiological parameter(s). For example, the system10may be configured to determine physiological parameters such as heart rate, temperature, blood pressure (e.g., systolic blood pressure, diastolic blood pressure, mean blood pressure), blood flow rate, blood velocity, pulse wave speed, volumetric flow rate, reflected pressure wave amplitude, augmentation index, flow reserve, resistance reserve, resistive index, capacitance reserve, hematocrit, heart rhythm, electrocardiogram (ECG) tracings, body fat percentage, activity level, body movement, falls, gait analysis, seizure activity, blood glucose levels, drug/medication levels, blood gas constituents and blood gas levels (e.g., oxygen, carbon dioxide, etc.), lactate levels, hormone levels (such as cortisol, thyroid hormone (T4, T3, free T4, free T3), TSH, ACTH, parathyroid hormone), and/or any correlates and/or derivatives of the foregoing measurements and parameters (e.g., raw data values, including voltages and/or other directly measured values). In some embodiments, one or more of the physiological measurements can be utilized or characterized as a physiological parameter without any additional processing by the system10.

The system10may also determine and/or monitor derivatives of any of the foregoing physiological parameters (also referred to herein as “physiological parameters”), such as a rate of change of a particular parameter, a change in a particular parameter over a particular time frame, etc. As but a few examples, the system10may be configured to determine as temperature over a specified time, a maximum temperature, a maximum average temperature, a minimum temperature, a temperature at a predetermined or calculated time relative to a predetermined or calculated temperature, an average temperature over a specified time, a maximum blood flow, a minimum blood flow, a blood flow at a predetermined or calculated time relative to a predetermined or calculated blood flow, an average blood flow over time, a maximum impedance, a minimum impedance, an impedance at a predetermined or calculated time relative to a predetermined or calculated impedance, a change in impedance over a specified time, a change in impedance relative to a change in temperature over a specified time, a change in heart rate over time, a change in respiratory rate over time, activity level over a specified time and/or at a specified time of day, and other suitable derivatives.

Measurements may be obtained continuously or periodically at one or more predetermined times, ranges of times, calculated times, and/or times when or relative to when a measured event occurs. Likewise, physiological parameters may be determined continuously or periodically at one or more predetermined times, ranges of times, calculated times, and/or times when or relative to when a measured event occurs.

Based on the determined physiological parameters, the system10of the present technology is configured to provide an indication of the patient's health to the patient and/or a clinician. For example, the controller112may compare one or more of the physiological parameters to a predetermined threshold or range and, based on the comparison, provide an indication of the patient's health. For instance, if the determined physiological parameter(s) is above or below the predetermined threshold or outside of the predetermined range, the system10may provide an indication that the patient is at risk of, or has already developed, a medical condition characterized by symptoms associated with the determined physiological parameters. As used herein, a “predetermined range” refers to a set range of values, and “outside of a/the predetermined range” refers to (a) a measured or calculated range of values that only partially overlap the predetermined range or do not overlap any portion of a predetermined range of values. As used herein, a “predetermined threshold” refers to a single value or range of values, and a parameter that is “outside” of “a predetermined threshold” refers to a situation where the parameter is (a) a measured or calculated value that exceeds or fails to meet a predetermined value, (b) a measured or calculated value that falls outside of a predetermined range of values, (c) a measured or calculated range of values that only partially overlaps a predetermined range of values or does not overlap any portion of a predetermined range of values, or (d) a measured or calculated range of values where none of the values overlap with a predetermined value.

Predetermined parameter thresholds and/or ranges can be empirically determined to create a look-up table. Look-up table values can be empirically determined, for example, based on clinical studies and/or known healthy or normal values or ranges of values. The predetermined threshold may additionally or alternatively based on a particular patient's baseline physiological parameters.

Medical conditions detected and/or indicated by the system10may include, for example, sepsis, pulmonary embolism, metastatic spinal cord compression, anemia, dehydration/volume depletion, vomiting, pneumonia, congestive heart failure, performance status, arrythmia, neutropenic fever, acute myocardial infarction, pain, opioid toxicity, nicotine or other drug addiction or dependency, hyperglycemic/diabetic ketoacidosis, hypoglycemia, hyperkalemia, hypercalcemia, hyponatremia, one or more brain metastases, superior vena cava syndrome, gastrointestinal hemorrhage, immunotherapy-induced or radiation pneumonitis, immunotherapy-induced colitis, diarrhea, cerebrovascular accident, stroke, pathological fracture, hemoptysis, hematemesis, medication-induced QT prolongation, heart block, tumor lysis syndrome, sickle cell anemia crisis, gastroparesis/cyclic vomiting syndrome, hemophilia, cystic fibrosis, chronic pain, and/or seizure.

FIG.4is a schematic block diagram of an environment for communication between an implantable device400, an interrogation device450, and one or more remote computing devices470. The implantable device400can be a vascular access device (e.g., the device100described above with respect toFIGS.1-3). In some embodiments, the implantable device400can be another implantable medical device, for example, a pacemaker, implantable cardioverter/defibrillator (ICD), deep brain stimulator, insulin pump, infusion port, orthopedic device, pulmonary artery pressure monitor, or any other implantable medical device with electronic sensing components.

The interrogation device450can be, for example, a handheld device configured to communicate wirelessly with the implantable device400when the device400is implanted within a patient. This communication can be carried out using a short-range connection (e.g., near-field communication (NFC), infrared wireless, Bluetooth, ZigBee, Wi-Fi, inductive coupling, or capacitive coupling) or other suitable wireless communication link. In various embodiments, the implantable device400and/or the interrogation device450can communicate with one or more remote computing devices470, for example over a network connection such as the Internet.

In the illustrated embodiment, the implantable device400can include a battery402(e.g., a rechargeable battery or other power source), and memory404. The memory404can include read-only memory (ROM) and random access memory (RAM) or other storage devices such as SSDs that store the executable applications, test software, databases and other software required to, for example, implement the various routines described herein, control device components, communicate and exchange data and information with remote computers and other devices, etc. The implantable device400can include a number of electronic elements (e.g., the memory404, sensing elements110, coil408, the localization unit410, and/or the data communications unit412). Some or all of these elements can include one or more processors, analog-to-digital converters, data storage devices, wireless communication antennas, and other associated elements. Some or all of these elements can be electronically coupled to or carried by a printed circuit board (e.g., a rigid or flexible PCB) or other suitable substrate. In some embodiments, software or firmware stored in the memory404or on a microprocessor unit can be configured to optimize data collection, communication, localization, and battery life of the device400.

The implantable device400includes sensing elements110configured to obtain one or more physiological measurements while implanted within the body. As described above with respect toFIGS.1-3, the sensor elements110can be configured to obtain any number of different physiological measurements and/or one or more other physiological parameters. For the example, the sensor elements110may be configured to determine physiological parameters such as heart rate, temperature, blood pressure (e.g., systolic blood pressure, diastolic blood pressure, mean blood pressure), blood flow rate, blood velocity, pulse wave speed, volumetric flow rate, reflected pressure wave amplitude, augmentation index, flow reserve, resistance reserve, resistive index, capacitance reserve, hematocrit, heart rhythm, electrocardiogram (ECG) tracings, body fat percentage, activity level, body movement, falls, gait analysis, seizure activity, blood glucose levels, drug/medication levels, blood gas constituents and blood gas levels (e.g., oxygen, carbon dioxide, etc.), lactate levels, hormone levels (such as cortisol, thyroid hormone (T4, T3, free T4, free T3), TSH, ACTH, parathyroid hormone), and/or any correlates and/or derivatives of the foregoing measurements and parameters (e.g., raw data values, including voltages and/or other directly measured values).

The device400can also include a coil408, for example a length of electrically conductive wire or other material that is wrapped to form a circular coil or other shape. In some embodiments, the coil408can be a conductive wire that encircles the reservoir414of the device400. The coil408can be electrically coupled to the battery402such that electrical energy received via the coil408can be used to recharge the battery402. The coil408can also be electrically coupled to the localization unit410such that electrical energy received via the coil408causes the localization unit410to emit a localization signal. Additionally, the coil408can be electrically coupled to the data communications unit412such that electrical energy received via the coil408causes the data communications unit412to perform certain actions, for example securely transmitting data to the interrogation device450. As described in more detail below, the coil408can be inductively coupled to a coil456of the interrogation device450to wirelessly receive electrical energy from the coil456. In some embodiments, the wireless energy is transmitted via capacitive coupling rather than inductive coupling.

With continued reference toFIG.4, the implantable device400further includes a localization unit410. The localization unit410can include an emitter configured to emit a localization signal in addition to a controller (e.g., a central processing unit, digital signal processor, application-specific integrated circuit, or any other logic processing unit) that reads instructions from the memory404to perform suitable operations or performs operations based on firmware stored on a microprocessor unit. The localization unit410can be configured to emit one or more localization signals from the implantable device400to aid a clinician in identifying the location of the device400when implanted within a patient. As noted previously, in some embodiments the localization unit410is configured to emit a localization signal in response to detecting the presence of the interrogation device450. For example, the coil456of the interrogation device450can be driven with an alternating current suitable to induce a current in the coil408of the implantable device400when the two devices are held in proximity to one another. The induced electrical current in the coil408of the implantable device can, in turn, cause the localization unit410to emit a localization signal. In some embodiments, the interrogation device450can include a localization reader466that is configured to read, detect, or otherwise identify a localization signal emitted by the localization unit410of the implantable device410. In other embodiments, the localization reader466can be omitted from the interrogation device450, and a clinician may directly observe the localization signal emitted by the localization unit450.

In various embodiments, the localization unit410can take a variety of forms, having different configurations of emitters configured to emit different localization signals, and a corresponding localization reader466of the interrogation device450can be configured to read or detect the particular localization signal emitted by the localization unit410. In each of the following examples, in some embodiments the interrogation device450may not include a localization reader466, and instead the localization signal emitted from the localization unit410of the implantable device400may be read, observed, or detected either directly by the clinician or by using another suitable instrument. In one example, the localization unit410can include one or more light sources disposed about the device100, and the localization signal can include the emission of light from the light sources. The emitted light can be configured to transilluminate the skin to indicate a location of the implantable device400to a clinician. In this instance, the localization reader466can include a light sensor or array of sensors configured to identify the lights transilluminating the patient's skin.

In further examples, the localization signal may take a variety of other forms. In some embodiments, the localization unit410includes a speaker configured to emit an audible sound as the localization signal, and the localization reader466includes a microphone or other device configured to detect the emitted sound and to localize its source. In some embodiments, the localization unit410includes one or more magnets (e.g., permanent magnets or electromagnets), and the localization signal includes the magnetic field generated by the magnets. For example, a plurality of magnets may be disposed around a reservoir of the implantable device400, and the magnetic field generated by these magnets may be detected by the localization reader466of the interrogation device450in a manner that indicates the location of the reservoir or other aspect of the implantable device400. In some embodiments, the localization unit410includes a radiofrequency transmitter, and the localization signal includes a radiofrequency signal that can be detected by the interrogation device450. In this instance, the localization reader466can be an antenna or other device configured to detect the signature radiofrequency signal emitted by the interrogation device and to localize the source of the signals. In some embodiments, the localization unit410includes an actuator configured to move or vibrate certain elements to serve as the localization signal. In some embodiments, the localization unit410includes one or more ultrasound transducers, and the emitted ultrasound serves as a localization signal to be detected by the localization reader466interrogation device450. In some embodiments, the localization unit410includes at least one moveable member that can create temporary a protrusion raising from an upper surface of the implantable device such that the protrusion can be palpated by a clinician to localize the device400. In some embodiments, the localization unit410includes a radioisotope and the localization signal comprises the electromagnetic radiation emitted by the radioisotope. For example, the localization unit410may include a retractable shield that absorbs radiation emitted by the radioisotope. To emit the localization signal, the localization unit410can cause the shield to be retracted, thereby allowing the radiation emitted by the radioisotope to escape the device400to be detected by the localization reader466of the interrogation device450. In some embodiments, the localization unit410includes a heating element and the localization signal is the increased heat signature radiating from the heating element. The increased temperature can be detected via a thermal camera, temperature sensor, or other suitable element of the localization reader466. In some embodiments, the localization unit410can cause the data communications unit412to send patient data or other identifying data to serve as a localization signal. The localization reader466may identify the source of the signal by triangulating its position to identify the location of the device400.

In some embodiments, the localization unit410determines whether to emit a localization signal based on a characteristic of the interrogation device450that induces a current in the coil408of the implantable device400. For example, the localization unit410may assess a characteristic such as a field intensity threshold of electrical energy received from the interrogation device450, a frequency of the electrical energy received from the interrogation device450, etc. These characteristics can aid in discriminating between a trusted interrogation device (i.e. an interrogation device suitable for pairing) and a non-trusted interrogation device (i.e., an interrogation device unsuitable for pairing), such that only pre-authorized interrogation devices450are able to cause the localization unit410to emit a localization signal.

The implantable device400also includes a data communications unit412that is configured to communicate wirelessly with the interrogation device450(via communications link460). Communication between the data communications unit412and the interrogation device450can be mediated by, for example, near-field communication (NFC), infrared wireless, Bluetooth, ZigBee, Wi-Fi, inductive coupling, capacitive coupling, or any other suitable wireless communication link. The data communications unit412may transmit data including, for example, physiological measurements obtained via the sensing elements110, patient medical records, device performance metrics (e.g., battery level, error logs, etc.), or any other such data stored by the implantable device400. As described in more detail below, the data communications unit412can utilize a variety of techniques to encrypt or otherwise obfuscate the data to maintain security during transmission to the interrogation device450. The data communications unit412may also receive data from the interrogation device450(via the communications link460). For example, the data communications unit412may receive instructions to obtain certain physiological measurements via the sensing elements110, to emit a localization signal via the localization unit410, or to perform other functions.

In some embodiments, the data communications unit412determines whether to emit a localization signal based on a characteristic of the interrogation device450that induces a current in the coil408of the implantable device400. For example, the data communications unit412may assess a characteristic such as a field intensity threshold of electrical energy received from the interrogation device450, a frequency of the electrical energy received from the interrogation device450, etc. These characteristics can aid in discriminating between a trusted interrogation device (i.e. an interrogation device suitable for pairing) and a non-trusted interrogation device (i.e., an interrogation device unsuitable for pairing), such that only pre-authorized interrogation devices450are able to cause the data communications unit412to transmit data to the interrogation device450.

In some embodiments, the implantable device400may also be in communication with the remote computing device(s)470over a wireless communications link (e.g., the Internet, public and private intranet, a local or extended Wi-Fi network, cell towers, etc.). The remote computing device(s)470can be, for example, server computers associated with a hospital, medical provider, medical records database, insurance company, or other entity charged with securely storing patient data and/or device data. In some embodiments, the obfuscated data provided by the data communications unit412can be de-obfuscated (e.g., unencrypted) at a remote location. In some embodiments, the implantable device400may be in direct communication only with the interrogation device450, which in turn is in communication with remote computing device(s)470.

The implantable device400can also include a reservoir414that is in fluid communication with an outlet port416. In use, a needle420can be removably inserted into the fluid reservoir414, and a catheter430can be fluidically coupled to the outlet port416, thereby establishing a fluid path between the needle420and the catheter430for introduction of fluid (e.g., medication) or withdrawal of fluid (e.g., aspiration of blood for testing). In some embodiments, the implantable device400may omit the reservoir or outlet port, for example in the case of pacemakers, deep brain stimulators, or other implantable devices that do not require delivery or extraction of fluids. In some embodiments, the implantable device400may include other elements that serve additional functions—for example a pacemaker can include a pacemaking unit configured to deliver current to cardiac leads, etc.

As noted previously, the implantable device400is configured to communicate wirelessly with the interrogation device450. The interrogation device450can be, for example, a special-purpose interrogation device, a smartphone (with or without associated accessory hardware such as a conductive coil), or other suitable computing device configured to communicate with the implantable device400. The interrogation device450can include a power source452(e.g., a battery or wired connection for external power), a memory454, and a processor458. In some embodiments, the interrogation device450can also include a display462(e.g., an electronic screen) configured to display information visually to a user, and an input464(e.g., buttons, a touch-screen input, etc.) configured to receive user input.

As noted above, the interrogation device450also includes a coil456configured to inductively couple with the coil408of the implantable device. For example, when the implantable device400and the interrogation device450are placed in proximity to one another, an alternating current driven through the coil456of the interrogation device450creates an alternating magnetic field that, in turn, induces an electrical current in the coil408of the implantable device. This induced current in the coil408can be used to recharge the battery402, cause the localization unit410to emit a localization signal, and/or to cause the data communications unit412to transmit data to or receive data from the interrogation device450.

As also noted above, the interrogation device450includes a communications link460configured to communicate with the data communications unit412of the implantable device400and/or to communicate with the remote computing device(s)470. The communications link460can include a wired connection (e.g., an Ethernet port, cable modem, FireWire cable, Lightning connector, USB port, etc.) or a wireless connection (e.g., including a Wi-Fi access point, Bluetooth transceiver, near-field communication (NFC) device, and/or wireless modem or cellular radio utilizing GSM, CDMA, 3G and/or 4G technologies).

As discussed previously, the interrogation device450can include a localization reader466that is configured to read, identify, or detect localization signals emitted via the localization unit410of the implantable device400. In various embodiments, the localization reader466can include a light sensor or array, a microphone or array of microphones, a magnetic field probe (e.g., an array of Hall effect sensors), an antenna or other radiofrequency receiver, an ultrasound receiver, an electromagnetic sensor, a temperature sensor, or any other transducer or sensor configured to detect, identify, or read a localization signal emitted via the localization unit410of the implantable device400.

Wireless Charging and Localization

As noted above, the advent of vascular access devices having on-board electronics requires a mechanism for powering such devices, and preferably for recharging a battery of such devices. Additionally, the on-board electronics may be used for localization, thereby obviating the need for bulky, protruding devices that are detectible via palpation of a patient's skin. As described in more detail below, an interrogation device that includes a coil can be used to wirelessly recharge an implanted vascular access device while also activating a localization signal. As a result, bringing an interrogation device into proximity with an implanted vascular access device causes the implanted vascular access device to be wirelessly recharged while emitting a localization signal that aids a clinician in correctly placing a needle into the fluid reservoir of the vascular access device.

FIGS.5A-7Billustrate various embodiments of an interrogation device450for use with an implantable device400such as a vascular access device. The interrogation device450includes a housing502that defines a central aperture504. In operation, the housing502can be placed against a patient's skin adjacent to the implantable device400such that the aperture504is substantially aligned with the device400. A clinician may then hold the interrogation device450in position or adhere it to the patient's skin, followed by insertion of a needle through the patient's skin and into the device400as described previously with respect toFIG.3.

Referring toFIGS.5A-5C, the housing502of the interrogation device450can assume a range of different geometries in various embodiments. For example, the housing502can define a substantially circular geometry, a rectangular or square geometry, a polygonal geometry, or any other shape that defines an aperture504. The general shape of the interrogation device450facilitates both wireless charging of the implantable device400as well as access to the implantable device400using a medical needle. Accordingly, the housing502of the interrogation device450defines a generally flat geometric shape enclosing a wire or other electrically conductive structure and other associated electronic components. The housing502may be circular, ovoid, rectangular, polygonal, or any other irregular shape that is designed to conform to the body. In some embodiments, the interrogation device450is flexible to conform to the external contour of the patient's skin, but in at least some embodiments the interrogation device450is rigid or semi-rigid, for example being made of plastic or metal, or of a semi-rigid medical grade material like polyurethane polymers or silicone in order to protect the inner electrical components.

In some embodiments, the size and shape of the central aperture504is configured to aid the user in accurately targeting a reservoir414of an implantable medical device400with a needle. In one embodiment, this aperture504is small enough to act as a tunnel to physically guide the needle into the center of a reservoir414of the implantable medical device400. For example, in some embodiments the aperture504may define an area having a size that is substantially similar to a cross-sectional size of the fluid reservoir414. In some embodiments, the area defined by the aperture504is smaller than a cross-sectional size of the fluid reservoir414. In another embodiment, the aperture504may be large enough to enable the user to access the reservoir414with a needle trajectory at least partially offset from the center axis of the reservoir414.

FIGS.6A-6Cillustrate the interrogation device450positioned in proximity to an implantable device400. The device400includes a reservoir414fluidically coupled to a catheter430. As best seen inFIG.6Cin which an upper portion of the housing502is removed, the housing502encloses the electronic components of the interrogation device450, including the power source452(e.g., a battery or a connection for a wired power source), the communications link460(e.g. a wireless antenna and associated electronics), and the coil456that is electrically coupled to the power source452. Although not illustrated here, in some embodiments the housing502may also contain a localization reader466or any other electronic components. When in use, the coil456(or other conductive material) can be driven with an alternating current, thereby inducing an alternating magnetic field within the central aperture504and aligned along an axis generally orthogonal to the patient's skin (i.e., generally orthogonal to the plane of the aperture504). When positioned over the implanted medical device400having a coil of conducting material (e.g., coil408), this alternating magnetic field induces an alternating electrical current within the coil408of the implantable device400which can be harvested for recharging a battery of the implantable device400or to perform other operations via the implantable device400.

In addition to recharging a battery of the implantable device400, the induced electrical current in the coil of the implantable device400may cause the implantable device400to emit a localization signal in response to the induced current. This remote activation of a localization signal allows for a smaller, lower profile design to the device that improves patient comfort and satisfaction with the device while still allowing for accurate cannulation of the device by a healthcare professional. As noted previously, the implantable device400can include a localization unit410configured to emit a localization signal in response to current induced via the interrogation device450. The localization signal can take a number of different forms, including, for example, visual output (e.g., lights), sound, tactile stimuli, vibration, magnetic fields, electromagnetic emissions, radioisotope decays, ultrasound, or any other means of localization that does not require palpation of the port device in its resting state. In one example, a plurality of LEDs are positioned around the reservoir414of the implantable device400. In response to the induced current from the interrogation device450, the LEDs emit light that transilluminates the patient's skin, allowing a clinician to localize the implantable device400.

FIGS.7A and7Billustrate another embodiment of the interrogation device450in which a membrane702extends over the aperture504defined by the housing502. The membrane702can be, for example, an adhesive material such that the interrogation device702can be adhered to a patient's skin. In some embodiments, the membrane702is a translucent or transparent medical adhesive such as TEGADERM. In some embodiments, the membrane702can be impregnated with therapeutic agents, for example an antimicrobial agent such as chlorhexidine, assisting with maintaining sterility of the procedure and preventing colonization of the implantable device400with infectious agents such as bacteria or fungi.

The addition of an adhesive material can aid a clinician in administering therapy via the implantable device400. For example, in instances in which the implantable device400is low profile, it may be difficult or impossible to localize via palpation, and accordingly additional means of localization may be required. The clinician, knowing the general anatomic location of the implantable device400, may place the interrogation device450over that anatomic region. Through inductive activation and power, the implantable device400may emit a localization signal, for example by activating a single or an array of LEDs that transilluminate through the skin, alerting the clinician of the precise location of the implantable device400. The clinician may then place the interrogation device450on the skin of the patient with the central aperture504directly over the implantable device400so that the LEDs are still visualized (or other localization signal is detected). The interrogation device450may rest on the skin of the patient. If a membrane702includes an adhesive, the adhesive may secure the interrogation device450in position on the skin of the patient.

With the interrogation device450resting on or adherent to the patient's skin, the clinician is free to use two hands for the access procedure. Through the central aperture504, the clinician may first sterilize the area of skin using a topical antiseptic such as chlorhexidine. Once the region is sterilized, using gloved hands, the clinician inserts a non-coring Huber type needle into the implantable device400using the LEDs as a visual guide for accurate needle placement (or using another suitable localization signal as a means for identifying the precise location of the reservoir for accurate needle placement). Using dressings, tape, or other adhesives such as TEGADERM, the needle is secured in place, attached to syringes or IV tubing, and then used for either aspiration of blood or infusion of therapeutic agents. For ease of use, all the components required for the access procedure including the interrogation device450may be packaged together in a single-use kit. In embodiments in which an adhesive such as TEGADERM covers at least a portion of the aperture504of the device450, the clinician may advance the needle through the adhesive to reach the implantable device400.

FIGS.8A and8Bare flow diagrams illustrating methods of localizing an implanted vascular access device in accordance with the present technology. With respect toFIG.8A, the method800begins in block802with receiving an induced electrical current at an implanted vascular access device400. For example, the implantable device400can receive an induced current as a response to placing the interrogation device450into proximity with the implantable device400and supplying alternating current to the coil456of the interrogation device450. The method800proceeds in block804with emitting a localization signal in response to the induced electrical current. In some embodiments, the induced electrical current is sufficient to fully power the emission of the localization signal (e.g., via the localization unit410of the implantable device400). In some embodiments, the vascular access device has no on-board battery, and the localization signal is powered entirely via the induced electrical current from an external device such as the interrogation device450. In other embodiments, the induced electrical current operates as a control signal to initiate emission of the localization signal, but the localization unit410draws additional power from the battery402in order to emit the localization signal.

As noted previously, the localization signal can take a variety of forms. For example, the localization signal can be light emitted from one or more light sources, sound emitted from one or more speakers, ultrasound emitted from one or more transducers, vibration or movement caused by one or more actuators, electromagnetic radiation, data transmission, heat emitted from a heating element, a magnetic field generated by one or more magnets, radiation emitted from a decaying radioisotope, or any other suitable signal that aids a clinician and/or an interrogation device450in localizing an implantable device400.

Turning now toFIG.8B, the method850begins in block852with providing a vascular access device configured to emit a localization signal in response to an induced electrical current. For example, the implantable medical device400can be positioned beneath a patient's skin at a target site, such as within the patient's chest. In block854, the method850continues with placing an interrogation device into proximity with the vascular access device. For example, the interrogation device450can be positioned over the patient's skin and substantially aligned with the implanted medical device400. In block856, alternating electrical current is applied to a coil of the interrogation device, thereby inducing electrical current at the vascular access device. This causes the vascular access device to emit the localization signal as described previously.

Data Communication and Security

While remote patient monitoring via an electronically equipped implantable device400provides many benefits to patients and clinicians, the risks to data security, privacy, and security of device operation all pose serious threats to safe and effective operation of such a device. Accordingly, the present technology provides a number of techniques for securely storing, transmitting, and receiving patient data, device data, control instructions, and any other sensitive information sent between an implantable device400and one or more external devices. The external devices can include an interrogation device450for local communication (e.g., near-field communication (NFC), infrared wireless, Bluetooth, ZigBee, Wi-Fi, inductive coupling, or capacitive coupling) and/or remote computing devices accessed over a network connection (e.g., an intranet, the Internet, etc.). The secure communication techniques described herein enable protection of private patient information and ensures protection from remote hacking and take-over of device operation.

FIGS.9A and9Bare flow diagrams illustrating methods of data communication between an implanted vascular access device such as the implantable device400and one or more remote computing devices (e.g., interrogation device450or remote computing device(s)470). Referring toFIG.9A, the method900begins with capturing physiological data from sensor elements110of a vascular access device400implanted within a patient. As noted above, the physiological data can include a wide variety of different measures or parameters, including, for example, heart rate, temperature, blood pressure (e.g., systolic blood pressure, diastolic blood pressure, mean blood pressure), blood flow rate, blood velocity, pulse wave speed, volumetric flow rate, reflected pressure wave amplitude, augmentation index, flow reserve, resistance reserve, resistive index, capacitance reserve, hematocrit, heart rhythm, electrocardiogram (ECG) tracings, body fat percentage, activity level, body movement, falls, gait analysis, seizure activity, blood glucose levels, drug/medication levels, blood gas constituents and blood gas levels (e.g., oxygen, carbon dioxide, etc.), lactate levels, hormone levels (such as cortisol, thyroid hormone (T4, T3, free T4, free T3), TSH, ACTH, parathyroid hormone), and/or any correlates and/or derivatives of the foregoing measurements and parameters (e.g., raw data values, including voltages and/or other directly measured values).

The method900continues in block904with obfuscating the physiological data, and in block906, the obfuscated physiological data is transmitted to the remote computing device(s). As described in more detail below, this obfuscation can take a number of different forms. This obfuscation can include, for example, encrypting data, parsing encrypted data into packets, and re-ordering the encrypted data packets, anonymizing data, use of blockchain technologies, or other methods for rendering communications unintelligible to anyone other than the intended recipient.

Referring now toFIG.9B, the method950includes receiving obfuscated physiological data based on sensor data from an implanted vascular access device. For example, the interrogation device450or a remote computing device470may receive the obfuscated physiological data from the implantable device400. This may be received over short-range wireless communication in the case of the interrogation device450, or a network communication in the case of the remote computing device(s)470. The method900continues in block954with de-obfuscating the obfuscated physiological data. As described below, in some embodiments the recipient device (e.g., the interrogation device450or the remote computing device470) utilizes algorithms and techniques to de-obfuscate the data in a manner that maintains the unintelligibility and inaccessibility of the obfuscated data to any persons or entities who intercept the obfuscated data during transmission between the implantable device400and the recipient device.

In one example, industry-standard algorithms (e.g., symmetric or asymmetric-key encryption) are used to encrypt the data via the data communications unit412of the implantable device400. The encrypted data may then be parsed into component parts such that the component packets are individually unintelligible. These components parts may then be assembled into a data stream and sent according to a scheme known only to the intended recipient. In at least some embodiments, unencrypted data may be parsed into component parts and sent according to a predetermined scheme. In some embodiments, the component parts may be separately encrypted after having been parsed into separate parts.

Data can be parsed in many ways. For example, data can be separated into individualized packets and compiled into a stream interspersed with filler data packets (e.g., packets that contain non-physiological data, random data, or other suitable filler data). In this scheme, the recipient may be provided with a key for identifying the filler data packets within the data stream. For example, the pattern of filler packets could be predetermined. For example, a reconstructed data stream may be as follows: 1 Kb data, 0.1 Kb filler, 1 Kb data, 0.3 Kb filler, 1 Kb data, 0.8 Kb filler. This pattern might be identified as 0.1-0.3-0.8 for decryption purposes, indicating sequence of data sizes for the filler packets. Filler packet sizes could also be defined by predetermined sequences, e.g. Fibonacci sequence or other patterned sequence. In some embodiments, data stream filler packet size patterns are used to encode start and stop points in the stream, analogous to the start and stop transcription instructions encoded in DNA for biologic systems. For example, when a sequence of packets has a file size pattern that matches a predetermined “code,” the recipient may identify the sequence as an instruction to start decrypting subsequent data packets or to take other action. Filler packet size or filler packet size sequence may also be used to communicate meta instructions, such as start reading, stop reading, skip to, change send/receive algorithm, overwrite existing data, system reset, revert to factory settings, pair with new device, change duty cycle, shutdown, etc.

In some embodiments, data is encrypted and divided into component packets. These packets are then re-ordered and assembled into a data stream for transmission. In some embodiments, the recipient may have prior knowledge of the re-ordering scheme (e.g. 1st 1 Kb, 3rd 1 Kb, 2nd 1 Kb, etc.). In some embodiments, data is encrypted and divided into incomplete blocks of unintelligible information and sent at time-delayed intervals with the recipient having prior knowledge of the time-delay sequence required for reconstruction of the encrypted data packets. In some embodiments, this re-ordering scheme may be used without initial encryption of the underlying data, as eavesdropping systems would likely either miss necessary portions of the data stream because of time delays or such eavesdropping systems would not be able to interpret the data stream because the data packets would have no identifying markers or patterns for reconstruction. Depending on device use requirements, time delays could be as short as picoseconds or as long as weeks. This transmission delay may be protective, especially with an implantable device, because the patient moves around her home and town throughout the day and week; so it becomes increasingly unlikely that an eavesdropping observing device or system would be in close enough proximity to receive enough of the data stream to reconstruct it, even if the observer knew the time delay algorithm.

As the transmitted data is being sent from an implantable device400, timing of data transmission may also be driven by the physical or physiologic state of the patient. For example, it may be advantageous to send data only while the patient is in a specific physical state like running, standing still, sleeping, or while the patient is experiencing a special physiologic event like low blood sugar, low oxygen saturation, low blood cell counts. In the former case, data transmission security is improved at least in part due to the unpredictable behavior of the patient, and transmission can also be controlled by the patient in this way. For example, the patient may choose to run for a few minutes to initiate data transmission, and in embodiments relying on short-range communication (e.g., Bluetooth low energy has a transmission range of approximately 30 feet) the patient's movement would enhance security by taking her out of range of any nearby eavesdropping devices. In some embodiments, physiologically-triggered data transmission can serve as an additional patient safety measure or emergency alert, for example by transmitting a full set of patient data if the patient experiences a diabetic, asthmatic, or trauma event as detected by the onboard sensing elements of the implantable device400.

In some embodiments, additional data obfuscation can be achieved by scattering incomplete blocks of unintelligible information through internet-based blockchain registries (e.g., Ethereum). In doing so, data could be retrieved by a remote receiver and interpreted based on a predetermined scheme or algorithmically derived interpretation methodology. In some embodiments, the component packets can be sent to different remote computing devices sequentially or in parallel. These component packets may then later be re-transmitted to a central computing device or group of computing devices for re-assembly and decryption.

To manage interpretation of data parsing schemes and data stream reconstruction, paired devices may use authentication software or authentication codes at the beginning and end of parsed data packets. In some embodiments, artificial intelligence may be employed for the sending device to autonomously create new data parsing schemes and to teach the receiving device how to interpret the schemes for incoming data. In this way, through repeated back-and-forth communication, the paired sender and receiver can evolve a unique language, or “slang” form of communication, known only to these paired devices, thereby making each successive communication more obscure and more difficult for a non-paired device, reader, system, or observer to interpret. For example, in such a scheme, the transmitting device may obfuscate physiological data according to a first technique (e.g., using interspersed filler packets according to a first pattern) and send the obfuscated data to a remote computing device. Subsequently, the transmitting device may obfuscate further physiological data according to a second technique different from the first (e.g., using interspersed filler packets according to a second pattern) and send the obfuscated data to the remote computing device for de-obfuscation. By varying the obfuscation techniques over time, the difficulty for an intercepting party (e.g., an entity using a man-in-the-middle attack) to decipher the obfuscated data.

An example of an autonomously evolving communication security system involves an implantable device400and an interrogation device450. The two devices may be programmed with the same initial communication obfuscation scheme. The process of pairing the implantable device400and the interrogation device450includes instructions for the two devices to begin autonomous evolution of their communication scheme (e.g., by evolving the pattern of filler packets, the time-delay sequence, or other such parameter of an obfuscation scheme). Communication evolution may be programmed to iterate quickly in order for the paired devices to quickly distinguish their language from any other devices. In one embodiment, the paired devices also retain their “native” originating language for communication with non-paired devices. In some embodiments, the paired devices do not retain their original language, making it impossible for non-paired devices to communicate with them. In this embodiment, the paired devices could be reprogrammed only by performing a hard reset, erasing all data and data communication schemes. The data erasure upon reset would serve as an added security measure. However, in alternative embodiments, the device may be reset without erasing the data communication scheme and/or without erasing the stored data. This embodiment may facilitate initial device research and development and use of paired devices when lower level security is acceptable.

In some embodiments, secure data transmission is achieved through a direct wireless connection between the implantable device400and the interrogation device450such as inductive coupling. This very short-range communication is far less likely to be intercepted by unintended recipients than, for example, Bluetooth communications which have a much longer range. In this embodiment, the coil408of the implantable device400is inductively coupled with the coil456of the interrogation device, allowing the two to communicate via very short-range direct wireless communication. In this embodiment, data may be encoded to the alternating current driving the coil408of the implantable device400utilizing amplitude modulation and/or frequency modulation schemes.

CONCLUSION

Although many of the embodiments are described above with respect to systems, devices, and methods for wireless charging, localization, and data communications for vascular access devices, the technology is applicable to other applications and/or other approaches, such as other types of implantable medical devices (e.g., pacemakers, implantable cardioverter/defibrillators (ICD), deep brain stimulators, insulin pumps, orthopedic devices, and monitoring devices such as pulmonary artery pressure monitors). Additionally, the present technology may be applied to other wireless charging, localization, or secure data communications techniques. Moreover, other embodiments in addition to those described herein are within the scope of the technology. Additionally, several other embodiments of the technology can have different configurations, components, or procedures than those described herein. A person of ordinary skill in the art, therefore, will accordingly understand that the technology can have other embodiments with additional elements, or the technology can have other embodiments without several of the features shown and described above with reference toFIGS.1-9B.

The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Where the context permits, singular or plural terms may also include the plural or singular term, respectively. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments.

Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, to between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.

Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.